NCT04653506View on ClinicalTrials.gov

Paracetamol / Ibuprofen for Postpartum Pain in the Early Postpartum Period

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

November 28, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

July 6, 2023

Conditions
Pain
Interventions
DRUG

Paracetamol 1000 mg

Women participating in the study will receive postpartum analgesia immediately while reporting pain requiring analgesia, by envelope contains paracetamol 1000 mg or ibuprofen 400 mg

DRUG

Ibuprofen 400 mg

Women participating in the study will receive postpartum analgesia immediately while reporting pain requiring analgesia, by envelope contains paracetamol 1000 mg or ibuprofen 400 mg

Trial Locations (1)

6423906

Tel Aviv Medical Center, Tel Aviv

All Listed Sponsors
lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV

NCT04653506 - Paracetamol / Ibuprofen for Postpartum Pain in the Early Postpartum Period | Biotech Hunter | Biotech Hunter